Last reviewed: June 26, 2026
Last updated: June 26, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Semaglutide and similar GLP-1 receptor agonists have become leading medications for weight management, but patients with low blood pressure—also called hypotension—often wonder whether these treatments are safe for them. Clinical research shows that GLP-1 medications typically lower blood pressure modestly in most patients, which means people with baseline hypotension need careful medical oversight before starting therapy.
How Semaglutide Affects Blood Pressure
Semaglutide works by slowing stomach emptying and signaling fullness to the brain, which naturally reduces calorie intake and often lowers blood pressure as a secondary benefit. Studies of patients without hypotension show average blood pressure drops of 5–8 mmHg systolic and 2–4 mmHg diastolic during treatment. This modest reduction helps many people with hypertension, but the same mechanism can pose challenges for those who already struggle with inadequate blood pressure.
The blood pressure-lowering effect stems partly from weight loss itself—as your body weight decreases, your heart works less hard to circulate blood, and blood vessel function improves. Additionally, GLP-1 activation triggers mild vasodilation (blood vessel relaxation) independent of weight loss, contributing to the overall blood pressure effect. For someone with existing low blood pressure, this combination requires monitoring to prevent symptoms like dizziness, fainting, or fatigue.
Understanding Hypotension and GLP-1 Safety
Hypotension exists on a spectrum; a reading of 90/60 mmHg is abnormally low and may cause symptoms, while readings around 100/65 mmHg are considered low-normal and often asymptomatic. Your prescribing physician must distinguish between your baseline blood pressure and what the medication might cause it to become. PlexusDx partners with licensed 503A compounding pharmacies and requires medical consultation to review your full health history, including blood pressure, before dispensing Semaglutide Injection or any GLP-1 therapy.
Contraindications aren't absolute; many people with mild hypotension use Semaglutide successfully under close supervision. The key is honest communication with your healthcare provider about dizziness, orthostatic hypotension (lightheadedness when standing), syncope history, or medications that lower blood pressure. Starting at the lowest effective dose and increasing gradually gives your cardiovascular system time to adapt.
Medical Monitoring During GLP-1 Treatment
If you have low blood pressure and are approved for Semaglutide, regular blood pressure checks become essential—ideally at home and during office visits. Monitor your blood pressure at consistent times (morning and evening), maintain detailed logs, and report any new symptoms to your provider immediately. Weight loss itself will gradually reduce your blood pressure, so your provider may need to adjust other medications or recommend lifestyle strategies like increasing salt intake slightly or staying well-hydrated.
PlexusDx recommends establishing a baseline before starting therapy and scheduling follow-up assessments at 2–4 weeks, then monthly, to track both weight and cardiovascular response. Your provider may also order labs to assess kidney and heart function, especially if you're on other medications. This proactive approach catches problems early and allows dose adjustment or discontinuation if your blood pressure drops dangerously low.
Personalized Treatment and Genetic Insights
Not everyone responds to GLP-1 medications identically; genetic factors influence how your body processes Semaglutide and how effectively it triggers weight loss and blood pressure changes. The PlexusDx Precision Peptide Genetic Test ($99 after your first month of treatment) analyzes 14 metabolic pathways involving 49 peptides, including key variants in the GLP1R gene (rs6923761) that correlate with individual medication response. Understanding your genetic profile helps your provider predict whether you'll experience significant blood pressure reduction and adjust your starting dose or monitoring intensity accordingly.
The test also examines variants in genes affecting appetite regulation (FTO rs9939609, MC4R rs17782313) and glucose-sensing (GIPR rs1800437), painting a complete picture of your peptide metabolism. This personalized data reduces trial-and-error dosing and helps identify whether a lower-dose microdose GLP-1 Protocol ($129/mo) or standard Semaglutide Injection ($149/mo) better matches your genetic predisposition. Armed with this insight, your provider can confidently recommend the safest starting point for your unique physiology.
Practical Steps Before Starting Semaglutide
Before initiating Semaglutide Injection at PlexusDx, gather recent blood pressure readings from home and any medical records documenting your hypotension history. Inform your prescribing physician about all current medications, supplements, and any syncopal episodes or orthostatic symptoms you've experienced. Discuss whether adjusting other blood-pressure-lowering drugs (ACE inhibitors, beta-blockers, diuretics) might be necessary once GLP-1 therapy begins.
Schedule your baseline appointment with PlexusDx to review your medical history, current blood pressure, and weight-loss goals. Your provider will confirm whether Semaglutide Injection is appropriate or suggest alternatives—for example, the oral formulation ($249/mo) has a different absorption profile and may produce milder blood pressure effects. PlexusDx operates across all 50 states without insurance requirements, so access is straightforward; HSA and FSA accounts cover treatment, reducing out-of-pocket costs.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
Can I use Semaglutide if my blood pressure is already low?
Possibly, but only under direct medical supervision. Your baseline blood pressure reading, symptom history, and other medications determine whether Semaglutide is safe for you. PlexusDx requires a full medical review before prescribing; many people with mild hypotension use GLP-1 therapy successfully with careful monitoring, while those with severe or symptomatic low blood pressure may need to explore alternatives or optimize other conditions first.
What is the typical blood pressure change from GLP-1 therapy?
Clinical trials show most patients experience a drop of 5–8 mmHg systolic and 2–4 mmHg diastolic during Semaglutide treatment, primarily from weight loss and mild vasodilation. For someone with normal blood pressure, this is beneficial; for someone with existing hypotension, it warrants close monitoring to keep readings above symptomatic thresholds (typically 90/60 mmHg or higher).
How much does Semaglutide cost at PlexusDx?
Compounded Semaglutide Injection starts at $149 per month and remains flat regardless of your dose—your dose may increase, but your price won't. PlexusDx serves all 50 states without insurance requirements or membership fees, and HSA/FSA accounts are eligible, making treatment accessible and affordable.
What side effects should I watch for if I have low blood pressure?
Beyond standard GLP-1 side effects (nausea, fatigue), watch for dizziness when standing quickly, fainting, blurred vision, or chest discomfort—all signs your blood pressure may be dropping too far. Report these immediately to your provider; blood pressure monitoring at home and regular check-ins catch dangerous drops before they cause harm.
How does PlexusDx genetic testing help with hypotension risk?
The Precision Peptide Genetic Test analyzes variants in GLP1R (rs6923761) and related metabolic genes that predict your individual response to Semaglutide, including how much your blood pressure may drop. This $99 test, available after your first month of treatment, allows your provider to personalize your starting dose and monitoring schedule, reducing the risk of problematic blood pressure changes.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
How Much Weight Can You Lose Per Month on Wegovy?
How to Give Yourself a Wegovy Injection: A Step-by-Step Guide